U.S. Food and Drug Administration
horizontal rule

Congressional Testimony

1996

September

  • Dr. Bruce Burlington, September 26, 1996
    Director, Center for Devices and Radiological Health, Food and Drug Administration, before the Subcomittee on Oversight and Investigations on medical diagnostic test.
  • Mary Pendergast, September 17, 1996
    Deputy Commissioner and Senior Advisor to the Commissioner, Food and Drug Administration before the Subcommittee on Technology, Committee on Science - Technological developments in genetic testing.

May

  • Sharon S. Holston, May 23, 1996
    Deputy Commissioner for External Affairs, Food and Drug Administration before the Committee on Transportation and Infrastructure, House of Representatives.
  • Michael Friedman, M.D., May 22, 1996
    Deputy Commissioner for Operations, Food and Drug Administration before the Submittee on Livestock, Dairy and Poultry, Committee on Agriculture.
  • David A. Kessler, M.D., May 2, 1996
    Commissioner of Food and Drug, Food and Drug Administration, before the Committee on Appropriations.
  • Michael Friedman, M.D., May 10, 1996
    Deputy Commissioner for Operations, Food and Drug Administration, Foodborne Illnesses, Subcommittee on Human Resources and Intergovernmental Relations House Committee on Government Reform and Oversight.

March

  • David A. Kessler, M.D., March 12, 1996
    Commissioner of Food and Drug, Food and Drug Administration, before the Subcommitee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, U.S. House of Representatives.

February

 

Testimony Archive

rule link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page